170 related articles for article (PubMed ID: 17413699)
1. Antimalarial activity of sera from subjects taking HIV protease inhibitors.
Redmond AM; Skinner-Adams T; Andrews KT; Gardiner DL; Ray J; Kelly M; McCarthy JS
AIDS; 2007 Mar; 21(6):763-5. PubMed ID: 17413699
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.
von Hentig N; Babacan E; Staszewski S; Stürmer M; Doerr HW; Lötsch J
Antivir Ther; 2007; 12(8):1237-46. PubMed ID: 18240863
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
Skinner-Adams TS; Andrews KT; Melville L; McCarthy J; Gardiner DL
Antimicrob Agents Chemother; 2007 Feb; 51(2):759-62. PubMed ID: 17088482
[TBL] [Abstract][Full Text] [Related]
4. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors.
Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Kiertiburanakul S; Anekthananon T; Bowonwatanuwong C; Kowadisaiburana B; Supparatpinyo K; Ruxrungtham K;
HIV Med; 2007 Nov; 8(8):529-35. PubMed ID: 17944686
[TBL] [Abstract][Full Text] [Related]
6. HIV-malaria interactions: don't forget the drugs.
Andrews KT; Gatton ML; Skinner-Adams TS; McCarthy JS; Gardiner DL
Science; 2007 Mar; 315(5820):1791; author reply 1791. PubMed ID: 17395812
[No Abstract] [Full Text] [Related]
7. Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
Hobbs CV; Gabriel EE; Kamthunzi P; Tegha G; Tauzie J; Petzold E; Barlow-Mosha L; Chi BH; Li Y; Ilmet T; Kirmse B; Neal J; Parikh S; Deygoo N; Jean Philippe P; Mofenson L; Prescott W; Chen J; Musoke P; Palumbo P; Duffy PE; Borkowsky W;
PLoS One; 2016; 11(12):e0165140. PubMed ID: 27936233
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
[TBL] [Abstract][Full Text] [Related]
9. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.
Bierman WF; van Agtmael MA; Nijhuis M; Danner SA; Boucher CA
AIDS; 2009 Jan; 23(3):279-91. PubMed ID: 19114854
[TBL] [Abstract][Full Text] [Related]
10. Antiretrovirals as antimalarial agents.
Skinner-Adams TS; McCarthy JS; Gardiner DL; Hilton PM; Andrews KT
J Infect Dis; 2004 Dec; 190(11):1998-2000. PubMed ID: 15529265
[TBL] [Abstract][Full Text] [Related]
11. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.
Pulido F; Arribas JR; Delgado R; Cabrero E; González-García J; Pérez-Elias MJ; Arranz A; Portilla J; Pasquau J; Iribarren JA; Rubio R; Norton M;
AIDS; 2008 Jan; 22(2):F1-9. PubMed ID: 18097218
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
13. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children.
Larrú B; Resino S; Bellón JM; de José MI; Fortuny C; Navarro ML; Gurbindo MD; Ramos JT; Soler Palacín P; Léon JA; Asensi M; Mellado MJ; Muñoz-Fernández MA
J Antimicrob Chemother; 2008 Jan; 61(1):183-90. PubMed ID: 18025025
[TBL] [Abstract][Full Text] [Related]
14. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
Jaspan HB; Berrisford AE; Boulle AM
Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
[TBL] [Abstract][Full Text] [Related]
15. Increasing choices for HIV therapy.
Hammer SM
N Engl J Med; 2002 Jun; 346(26):2022-3. PubMed ID: 12087136
[No Abstract] [Full Text] [Related]
16. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.
Andrews KT; Fairlie DP; Madala PK; Ray J; Wyatt DM; Hilton PM; Melville LA; Beattie L; Gardiner DL; Reid RC; Stoermer MJ; Skinner-Adams T; Berry C; McCarthy JS
Antimicrob Agents Chemother; 2006 Feb; 50(2):639-48. PubMed ID: 16436721
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of highly active antiretroviral therapy in HIV-infected patients.
Jensen-Fangel S
Dan Med Bull; 2004 Nov; 51(4):371-92. PubMed ID: 16009063
[No Abstract] [Full Text] [Related]
18. Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
Mallolas J; Blanco J; Labarga P; Vergara A; Ocampo A; Sarasa M; Arnedo M; López-Púa Y; García J; Juega J; Guelar A; Terrón A; Dalmau D; García I; Zárraga M; Martínez E; Carné X; Pumarola T; Escayola R; Gatell J
HIV Med; 2007 May; 8(4):226-33. PubMed ID: 17461850
[TBL] [Abstract][Full Text] [Related]
19. Delavirdine increases drug exposure of ritonavir-boosted protease inhibitors.
Harris M; Alexander C; O'Shaughnessy M; Montaner JS
AIDS; 2002 Mar; 16(5):798-9. PubMed ID: 11964540
[No Abstract] [Full Text] [Related]
20. ART regimen protects children from malaria.
BMJ; 2012 Dec; 345():e8214. PubMed ID: 23207506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
